What We're Reading: Page 203
Industry reads hand-picked by our editors
Feb 20, 2020
Feb 19, 2020
-
The Boston Globe
Founder of Medford biotech who defrauded investors of $7.5m gets 7 years in prison
-
BioCentury
The Phase III trials and pharma sales most likely to be disrupted by COVID-19
-
OneZero
The Price of DNA Sequencing Dropped From $2.7 Billion to $300 in Less Than 20 Years
-
Pittsburgh Business Times
Mylan-Upjohn merger filings contemplate coronavirus impact
Feb 18, 2020
-
The Wall Street Journal
Gilead’s Coronavirus Drug Trial Slowed by Lack of Eligible Recruits
-
C&EN
Could an NLRP3 inhibitor be the one drug to conquer common diseases?
-
The New York Times
Payout From a National Opioids Settlement Won't Be as Big as Hoped
-
STAT
'Pharma doesn’t like fish oil': Wall Street funds sold Amarin after big win with heart drug
Feb 14, 2020
-
Regulatory Focus
Internal FDA Emails Reveal How Price, Sanders's Pressure Played a Role in Competitor's Approval, Catalyst Claims
-
Endpoints News
Carl June on CRISPR, CAR–T and how the Vietnam War dropped him into medicine
-
Reuters
Gilead drug prevents type of coronavirus in monkeys; raises hope for China trials
Feb 13, 2020
-
The Wall Street Journal
Coronavirus-Drug Development Becomes a Top Focus at Gilead
-
New England Journal of Medicine
The Magic of Randomization versus the Myth of Real-World Evidence
-
Bloomberg
Elizabeth Holmes Gets Fraud Case Narrowed, Not Dismissed
Feb 12, 2020
-
MIT Technology Review
The coronavirus is the first true social-media "infodemic"
-
Bloomberg
Chinese Firm Makes Gilead Drug in Virus Fight, Raising IP Fears
-
The Philadelphia Inquirer
Merck to open outpost at Center City WeWork, as big companies see coworking as a passage into Philly
-
Healthcare Dive
CVS swings to $6.6B profit in 2019, buoyed by Aetna
Feb 11, 2020
-
Regulatory Focus
Interview With FDA's OND Director: Approval Standards, Transparency and More
-
STAT
Priscilla Chan's unglamorous quest to fight disease. (Mark is involved, too.)
-
The Economist
Run, don’t walk - The race to produce a vaccine for the latest coronavirus
-
Bloomberg
Trump Eyes Drug-Price Cuts After His Health-Care Record Assailed
Previous
